A big moment at the Forbes Healthcare Summit last month: I was on stage with the R&D chief of three of the biggest drug companies on the planet. Roger Perlmutter, formerly of Amgen AMGN +0.77% but now head of research at Merck , talked about what it means to pare down R&D headcount – something his company had just done the week before.
Help employers find you! Check out all the jobs and post your resume.
